
Request appointment
500 Westchester AvenueWest Harrison, NY 10604
Overview of Dr. Guttmann
I am a Radiation Oncologist at Memorial Sloan Kettering Cancer Center seeing patients at our Westchester and Bergen County locations. I received my medical degree from Perelman School of Medicine at the University of Pennsylvania and completed by Residency in Radiation Oncology at the Hospital of the University of Pennsylvania in 2018. I am in experienced in treatment of prostate cancer, breast cancer, lung cancer, gastrointestinal cancers, and metastatic disease including brain and spinal cord tumors.
Education & Training
University of Pennsylvania Health SystemResidency, Radiation Oncology, 2013 - 2018
University of PennsylvaniaM.T.R., Translational Research, 2011 - 2013
Perelman School of Medicine at the University of PennsylvaniaClass of 2013
Brown UniversitySc.B., Biochemistry, Phi Beta Kappa, Magna Cum Laude, 2003 - 2007
Certifications & Licensure
FL State Medical License 2023 - Present
NY State Medical License 2018 - 2028
CT State Medical License 2023 - 2027
NJ State Medical License 2018 - 2027
NC State Medical License 2021 - 2022
PA State Medical License 2013 - 2018
American Board of Radiology Radiation Oncology- AHAACLS
Awards, Honors, & Recognition
- Alpha Omega Alpha University of Pennsylvania, 2013
- Fulbright Fellowship Weizmann Institute of Science, Rehovot, Israel, 2013
- Graduation with Honors Thesis in Biochemistry Brown University, 2007
Clinical Trials
- A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer Start of enrollment: 2023 May 17
Roles: Contact
Publications & Presentations
PubMed
- Patient selection and toxicity predictors in proton reirradiation for locoregional breast cancer recurrence.Molly A Chakraborty, Charlie White, Atif J Khan, Siyu Yang, Zhigang Zhang
Clinical and Translational Radiation Oncology. 2026-09-01 - A Phase I Study of Cyclical Hypofractionated Palliative Radiotherapy (Quad Shot) for Central Lung Tumors in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC): ...Y Helen Zhang, Afsheen Iqbal, Daphna Gelblum, Jennifer Ma, Ellen Yorke
International Journal of Radiation Oncology, Biology, Physics. 2026-08-18 - Prophylactic Versus Therapeutic Sucralfate in Patients at High Risk for Radiation Esophagitis: Randomized Controlled Trial.Jacob Y Shin, Melissa Assel, Abraham J Wu, Daphna Y Gelblum, David M Guttmann
Practical Radiation Oncology. 2026-06-16
Abstracts/Posters
- Radiation Dermatitis and Modality Predict Wound Complications in Patients with Soft Tissue Sarcoma.LeBrun DG, Guttmann DM, Levin WP, Kovach SJ, Weber KL, American Academy of Orthopedic Surgeons Annual Meeting, 1/1/2017
- Head and Neck Cancer Survival Outcome Prediction Based on NRG Oncology RTOG 0522 with Random Forests and Random Survival Forests.Huang M, Cheng C, Geng H, Zhong H, Wang J, Lin A, Guttmann D, Soest J, Dekker A, Bilker W, Zhang Z, Rosenthal D, Axelrod R, Galvin J, Frank S, Thorstad W, Huth B, Hsu ..., American Association of Physicists in Medicine Annual Meeting, 1/1/2017
- Evaluation of a Knowledge-Based Atlas for Automated Cardiac Structures Quality Assurance for NCTN Clinical Trial NRG Oncology RTOG 0617 and 1308.Hunag M, Guttmann D, Yu J, Cheng C, Geng H, Zhong H, Gore E, Bradley J, Liao Z, Forster K, Gillin M, Mohan R, Xiao Y, American Association of Physicists in Medicine Annual Meeting, 1/1/2017
Other
- Clinical Outcomes by Disease Site - The Use of Proton Therapy in the Treatment of Cancers of the Central Nervous System. Proton therapy education moduleGuttmann DM, OncoLink.org
https://www.oncolink.org/healthcare-professionals/oncolink-university/proton-therapy-professional-education/oncolink-proton-education-modules
1/8/2015 - Clinical Outcomes by Disease Site - The Use of Proton Therapy in the Treatment of Cancers of the Connective Tissues and Bone. Proton therapy education moduleGuttmann DM, OncoLink.org
https://www.oncolink.org/healthcare-professionals/oncolink-university/proton-therapy-professional-education/oncolink-proton-education-modules
1/8/2015 - Clinical Outcomes by Disease Site - The Use of Proton Therapy in the Treatment of Cancers of the Head and Neck. Proton therapy education moduleGuttmann DM, OncoLink.org
https://www.oncolink.org/healthcare-professionals/oncolink-university/proton-therapy-professional-education/oncolink-proton-education-modules
1/8/2015
Press Mentions
FDA Approves Zenocutuzumab for Pancreatic and Lung Cancers with NRG1 FusionsDecember 5th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









